Register to receive a free U.S. Soft Tissue Reinforcement and Regeneration Market report synopsis and brochure

The overall U.S. orthopedic sports medicine market continues to show marked growth as Americans continue to enjoy increasingly active lifestyles. Consequently, the likelihood of traumatic injury and chronic strain on tendons will continue to increase. Tendon repair devices are most often used to reinforce severe tearing of either the rotator cuff or Achilles tendons.

Tendon reinforcement devices have been used extensively to treat severe rotator cuff ruptures but are limited by the increasing trend of the arthroscopic technique used for shoulder repair, which makes it difficult to overlay the reinforcement mesh. The total rotator cuff reinforcement market consists of allograft, xenograft and alloplast reinforcement devices. Market growth will be sustained as the number of procedures involving rotator cuff repair continues to grow, of which a constant percentage will be more severe and require additional augmentation on top of suture anchoring, increasing the demand for reinforcement products. The growth is expected to increase over the next few years as more surgeons become capable of using the reinforcement devices in arthroscopic procedures.

As demand increases for rotator cuff reinforcement devices as a result of the rising number of shoulder repair procedures performed on elderly patients, strong growth will continue to be observed in the market. The allograft segment was the largest of the three rotator cuff reinforcement device segments. Despite being more expensive, the exceptional performance and longstanding clinical history of allografts make them preferable to both xenograft and synthetic devices. The allograft segment saw more units sold at a higher ASP than the xenograft and alloplast segments.

Competition among an increasing number of companies will contribute to pricing pressure for manufacturers. This will be counterbalanced by the emergence of thicker biologic dermal reinforcement devices that will drive up the average selling price (ASP). The shoulder is a heavily used joint; to further reduce the likelihood of a postoperative re-tear, thicker versions of reinforcement devices are preferred for the rotator cuff. Rotator cuff reinforcement devices, on average, require slightly thicker products, which have a slightly higher price point. Therefore, the ASP is expected to grow moderately by 2021.

The large number of allograft device sales relative to the other segments is due to the popularity of Wright Medical’s GRAFTJACKET™ product, which dominated the allograft segment. The allograft segment will remain the most popular segment in the rotator cuff reinforcement market as allografts have been most successful in reducing the postoperative re-tear rate of the rotator cuff tendons. The segment will benefit from the increasing use of these products in arthroscopic procedures, which will further drive unit sales in the near future.

For Further Information
More on the markets for breast reconstruction in the U.S. can be found in the report published by iData entitled U.S. Soft Tissue Reinforcement and Regeneration Market, covers the U.S. market segments for hernia repair, dural repair, vaginal slings, skin repair, sports medicine and tendon reinforcement, and dental soft tissue regeneration.

The iData series on the market for soft tissue reinforcement and regeneration devices covers the U.S., and 15 countries in Europe. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.

Register online or email us at [email protected] for a U.S. Soft Tissue Reinforcement and Regeneration Market report brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter: